-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DdsR1mEHKfi5EIWuX9ghfPuSUxr61NWWzjomzkrsjp5aRADvpCSOlQdYfMOueecG uZtPVCcCPxG/nxLE/FX97g== 0000000000-09-064982.txt : 20100104 0000000000-09-064982.hdr.sgml : 20100101 20091117110106 ACCESSION NUMBER: 0000000000-09-064982 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20091117 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: QUESTCOR PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000891288 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330476164 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: UPLOAD BUSINESS ADDRESS: STREET 1: 3260 WHIPPLE ROAD CITY: UNION CITY STATE: CA ZIP: 94587-1217 BUSINESS PHONE: 5104000700 MAIL ADDRESS: STREET 1: 3260 WHIPPLE ROAD CITY: UNION CITY STATE: CA ZIP: 94587-1217 FORMER COMPANY: FORMER CONFORMED NAME: CYPROS PHARMACEUTICAL CORP DATE OF NAME CHANGE: 19930328 PUBLIC REFERENCE ACCESSION NUMBER: 0000950134-09-005448 LETTER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C0-)>+CS],-"C8@,"!O8FH-/#PO3&EN96%R:7IE9"`Q+TP@-S0T M."]/(#@O12`S,C$X+TX@,2]4(#!BZ=1]=B],*ZD#6`!1@8& M[F]0;59`S,K`('4)(L[P"R#``%2U"/,-"F5N9'-T7!E+T-A=&%L M;V7!E+U!A9V4^/@UE;F1O8FH-.2`P(&]B:@T\/"]&;VYT/#PO5%0R(#$P M(#`@4B]45#0@,3(@,"!2/CXO4')O8U-E=%LO4$1&+U1E>'1=+T5X=$=3=&%T M93P\+T=3,2`Q-2`P(%(^/CX^#65N9&]B:@TQ,"`P(&]B:@T\/"]3=6)T>7!E M+U1R=654>7!E+T9O;G1$97-C?%5-4]LP$+W[5^Q1ZL2. MY.]P*P0ZI0.EX`Z'3`^N+1-U')MQ'&C^?5>RI9@0&B;1ZF/?OK>[$O,O#QR> MMLYYYLRSS`<.6>5P'QC^X;!@D+#46\20;1P&3_C-"O7SZA"@V1\T7>[Q"++E MN)!].F7`3L1^WXR0'48XQQ=<8=K5=G16[;%T'= MV.-D0Q-O07Y3-$4'/)F!S]@"Z*_LVG&G.,>\,;H"]"VTK_>6;0,W'IPC7;&? M'@SMP7#@<->)K2Q%0R,O)#WD@U'"Q5J*"B[_BF+7RQ%9%XSJC\H#/V;P2!=X?$W15SX_ MUP+NV[R"!W+\Z`NMR/V$0CC9'FFG(O54)/:V1OZQU8]J-J1/63B"'$5=MM M@#/W&Z`$Z-<"]B+O0#2E*+%?YP&?8P.D`^Q$E&O[R+81N<(:EW"3=\4:>&PZ M!Q6[)[-A:6A'N&T]0"27ATDTQIOZV=SYT]R%'[0T62H5-YWIO+/CN_5!^_XG M4X\"UCGV7]%NL$5Z5-KN.NC$BQ2OT%:P5U--F^/]QBC,<#NZ$RN==)H2E7=U MZU+R#=N]1*PZ5[B5K&7SM%5KV,\^&>(V[9B4$7Y:87[@'0PA*AIZ`=EAFP2D MP[)VBC>VN;KAZE>H&][T&*3'JLLM!HH(]'+*&:)(U>) M1IB@I(;JTA9JGN)<&*/3AIY'`7!E+U1R M=654>7!E+T9O;G1$97-C7!E+T9O;G0^/@UE;F1O8FH-,3,@,"!O M8FH-/#PO4W1E;58@.#(O1F]N=$YA;64O5&EM97-.97=2;VUA;E!3350O1F]N M=%-T%LM-38X("TS,#<@,C`P,"`Q,#`W72]!7!E+T9O;G1$97-C%LM-34X M("TS,#<@,C`P,"`Q,#(V72]!7!E+T9O M;G1$97-C'1'4W1A=&4O4T$@ M9F%L7!E+UA-3"],96YG=&@@,S8Q."]4>7!E+TUE=&%D871A M/CYS=')E86T-"CP_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H M:4AZDY48WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z M;G,Z;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#0N,"UC,S$V(#0T M+C(U,SDR,2P@4W5N($]C="`P,2`R,#`V(#$W.C$T.C,Y(CX*("`@/')D9CI2 M1$8@>&UL;G,Z&UL;G,Z9&,](FAT='`Z+R]P=7)L+F]R9R]D M8R]E;&5M96YT"UD969A=6QT(CY-:6-R;W-O9G0@5V]R9"`M(%%U97-T8V]R(#$P M2R!.1D,@3&5T=&5R(#$Q,3&%P34TZ26YS M=&%N8V5)1#YU=6ED.C-A83%E,#,X+65E8S`M-&(R82UA9#8P+61D.&,Y-F5C M,#%E-#PO>&%P34TZ26YS=&%N8V5)1#X*("`@("`@/"]R9&8Z1&5S8W)I<'1I M;VX^"B`@(#PO')E9@T*,"`V#0HP,#`P,#`P M,#`P(#8U-3,U(&8-"C`P,#`P,#,R,3@@,#`P,#`@;@T*,#`P,#`P,S(U,B`P M,#`P,"!N#0HP,#`P,#`S,C -----END PRIVACY-ENHANCED MESSAGE-----